Bismuth Polymer for Medical Device Biocompatibility
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Medical devices that come into contact with blood, tissue, and body fluids often suffer from biocompatibility issues, leading to bacterial adhesion, biofilm formation, and inflammation, with existing antimicrobial solutions being ineffective or toxic.
Innovation Solution
A biocompatible polymer composition incorporating a bismuth complex at specific weight percentages, integrated into a polyurethane or polysiloxane-based film, which prevents bacterial adhesion and biofilm formation while maintaining non-toxicity and biocompatibility.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If conventional materials are used for medical devices contacting blood and tissue, then manufacturing is simple and cost-effective, but biocompatibility deteriorates leading to blood clotting, inflammation, and tissue activation
Solution Approach 1:
The patent modifies the chemical composition parameters of the polymer material by incorporating specific additives (bismuth compounds, silver salts, or other antimicrobial agents) at controlled concentrations. This changes the material's biological properties to achieve biocompatibility and prevent blood clotting while maintaining manufacturing feasibility
Solution Approach 2:
The invention creates a composite polymer material combining base polymer with antimicrobial additives. This composite structure provides both the mechanical properties of the polymer and the biocompatibility/antimicrobial activity of the additives, resolving the contradiction between material simplicity and biological compatibility
2Reliability
If antimicrobial agents are added to prevent bacterial growth, then bacterial adhesion and biofilm formation are reduced, but material toxicity increases
Solution Approach 1:
The patent optimizes the concentration parameters of antimicrobial additives within specific ranges (e.g., 0.01-10 wt%) to achieve effective bacterial inhibition while maintaining non-toxicity. This parameter optimization resolves the contradiction between antimicrobial efficacy and material safety
Solution Approach 2:
The invention uses bismuth compounds and silver salts that can be easily removed or degraded over time, minimizing long-term toxicity concerns. These additives provide temporary antimicrobial protection during the critical healing period without causing persistent harm to the host
3Reliability
If bismuth compounds are applied to protect against microbial attack, then antimicrobial activity is enhanced, but manufacturing complexity increases
Solution Approach 1:
The patent incorporates antimicrobial agents during the polymer fabrication process itself, rather than requiring separate post-manufacturing treatment steps. This preliminary incorporation simplifies manufacturing by integrating multiple functions into a single production process
Solution Approach 2:
The invention specifies optimal concentration ranges and forms of bismuth compounds that can be easily incorporated into standard polymer processing methods. This parameter guidance maintains manufacturing simplicity while achieving effective antimicrobial protection
Data Source
AI summary
The present disclosure relates to a biocompatible polymer composition for an article comprising a surface intended to contact blood, tissue, skin, epithelial layers, wounds, cells in culture fluids, body fluids, dialysis fluids, therapeutic fluids, or mixtures thereof for removal or infusion. The invention also relates to a method for the preparation of an article comprising the biocompatible polymer composition and a use thereof.